Status: On trackCV-118
Sponsor viewShared with Helios Cardio
Helios Cardio
CV-118 · Reduction of MACE in post-MI patients with elevated Lp(a)
Phase 3Follow-upCardiovascularOn track
Executive summary
Event-driven CV outcomes Ph3. All randomisation complete; in long-term follow-up. Event accrual is on plan and interim analysis 2 closed with DSMB recommendation to continue unchanged.
Phase
Phase 3
Stage
Follow-up
Health
On track
Milestone timeline
Showing completed, in-progress, and at-risk milestones. Planned future milestones are omitted from the sponsor view.
May 15, 2021forecast end Jul 5, 2027
- Complete
FPI
May 22, 2021
- Complete
25% enrolment
Apr 12, 2022
- Complete
50% enrolment
Dec 4, 2022
- Complete
75% enrolment
Sep 8, 2023
- Complete
LPI
May 21, 2024
- In progress
LPLV
Oct 5, 2026
Signed deliverables
Updated live as deliverables are signed.
- Essential Documentsfiled and signed
- Audit Trailgreen
- CSR draftnot yet released to sponsor
Request an update
Ask for a status update, request a document, or submit a question. The study lead is notified and you’ll see the response in this portal.